Table II.
Correlation of IMT with atherosclerotic risk factors and disease variables
| Outcome | Variable | N | rho | 95%CI | P value |
|---|---|---|---|---|---|
| IMT | BMI | 44 | 0.19 | (−0.12,0.49) | 0.23 |
| IMT | Systolic blood pressure | 45 | 0.37 | (0.09,0.66) | 0.012 |
| IMT | Diastolic blood pressure | 45 | 0.38 | (0.09,0.66) | 0.011 |
| IMT | Creatinine | 45 | 0.35 | (0.06,0.64) | 0.019 |
| IMT | HDL | 45 | −0.21 | (−0.51,0.10) | 0.18 |
| IMT | LDL | 45 | −0.19 | (−0.50,0.11) | 0.2 |
| IMT | FBG | 45 | 0.12 | (−0.18,0.43) | 0.42 |
| IMT | Age at onset of disease | 45 | 0.54 | (0.28,0.80) | <0.001 |
| IMT | Disease Duration | 45 | 0.23 | (−0.07,0.53) | 0.13 |
| IMT | Azathioprine Duration | 45 | −0.24 | (−0.53,0.06) | 0.12 |
| IMT | Methotrexate Duration | 45 | 0.11 | (−0.20,0.41) | 0.48 |
| IMT | Cyclophosphamide Duration | 45 | −0.13 | (−0.43,0.18) | 0.41 |
| IMT | Cumulative Dose of cyclophosphamide | 45 | −0.15 | (−0.45,0.16) | 0.34 |
Abbreviations: BMI, bosy mass index; CI, confidence interval; FBG, Fasting blood glucose; HDL, high density lipoprotein; IMT, Intima-media thickness; LDL, low density lipoprotein; N, number; ρ, Spearman’s rank correlation coefficient. Bold indicates statistical significant values.